Release Date: 19/06/14 16:52 Summary: DIRECTOR RESIGNATION Price Sensitive: No Download Document 135.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%